{
    "cancelStatus": "0",
    "cancelDate": null,
    "cancelReason": [],
    "licid": "02025884",
    "validDate": "2022-12-28 00:00:00.000",
    "issueDate": "2012-12-28 00:00:00.000",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA00202588403",
    "prodNameC": "利落脂寧緩釋膠囊135毫克",
    "prodNameE": "Trilipix® 135 mg modified release capsules",
    "indicationsName": [
        "本品適應症核定為(一)「與statin併用，治療混合型高血脂症。說明：混合型高血脂症併有冠心病(或與冠心病風險相當〔CHD risk equivalent〕)，且已接受最佳statin療法以達到LDL-C治療目標之病患，在配合飲食控制下，Trilipix可併用statin以降低三酸甘油酯及提昇 HDL-C。與冠心病風險相當者包括：其他臨床型態的動脈粥狀硬化疾病，如周邊動脈疾病、腹主動脈瘤及有症狀的頸動脈疾病；糖尿病；或帶有多重危險因子，預期10年內罹患CHD的風險＞20％。使用限制的重要資訊 ：相較於statin單獨療法，Trilipix對心血管的罹病率與死亡率並未產生額外的收益。在兩個大型、隨機分配、對照型試驗中，第二型糖尿病患者服用劑量與135mg Trilipix相當的fenofibrate，未顯示可以降低冠心病的罹病率與死亡率。(二)高脂質血症說明：成人內生性高膽固醇血症(type IIa)以及高三酸甘油酯血症，無論是type IV或是混合的type IIb與type III：1.當飲食療法控制不理想時。2.特別是在持續飲食控制之後膽固醇的濃度仍維持升高不變及\/或可證明有相關的危險因素存在。3.持續的飲食控制是必須的。4.目前，並無長期對照臨床試驗結果足以說明fenofibrate預防原發性與繼發性動脈粥狀硬化併發症的療效。」"
    ],
    "does": "1162",
    "packageUnit": [
        {
            "packageSpec": "2-1000粒",
            "packageUnit": "89"
        }
    ],
    "medMCode": "06",
    "maMedCode": null,
    "medDCode": null,
    "ingredientsDesc": [
        "Choline fenofibrate"
    ],
    "restraintItemsCode": [
        "02",
        "07",
        "1Q"
    ],
    "applicantName": "美商亞培股份有限公司台灣分公司",
    "applicantAddr": "台北市中山區民生東路三段49號5樓、6樓及51號6樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "FOURNIER LABORATORIES IRELAND LIMITED.",
            "factoryAddr": "ANNGROVE, CARRIGTWOHILL, CORK, IRELAND.",
            "factoryCompanyAddr": null,
            "countryCode": "IE",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FIE0067000",
            "factoryInfo": null,
            "qsd": null
        },
        {
            "factoryCode": "2",
            "factoryName": "MYLAN LABORATORIES SAS",
            "factoryAddr": "ROUTE DE BELLEVILLE, LIEU DIT MAILLARD 01400 CHATILLON-SUR-CHALARONNE, FRANCE ",
            "factoryCompanyAddr": "",
            "countryCode": "FR",
            "processCode": [
                {
                    "value": "02",
                    "name": "包裝"
                }
            ],
            "processCodeStr": "02;包裝",
            "factoryKind": "M",
            "factoryNo": "FFR0263100",
            "factoryInfo": null,
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "2406002420",
            "ingredientsDesc": "Choline fenofibrate",
            "concentDesc": null,
            "concent": "14.900",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [
        {
            "licChgDocId": "9DB49A84-F215-48D6-B7C7-89AF8FCAF1A5",
            "approvedDocNo": "1086039226",
            "approvedDate": "2020-09-04",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        }
    ],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "C10AB11"
        }
    ],
    "licBaseId": "9D7F95D0-1E24-4DD1-A1E3-4590698A21C1"
}